A detailed history of Mariner, LLC transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Mariner, LLC holds 31,292 shares of ELAN stock, worth $437,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
31,292
Previous 31,296 0.01%
Holding current value
$437,462
Previous $451,000 1.77%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$11.85 - $15.47 $47 - $61
-4 Reduced 0.01%
31,292 $459,000
Q2 2024

Aug 13, 2024

SELL
$12.93 - $18.45 $115,542 - $164,869
-8,936 Reduced 22.21%
31,296 $451,000
Q1 2024

May 15, 2024

SELL
$14.37 - $16.46 $8,104 - $9,283
-564 Reduced 1.38%
40,232 $654,000
Q4 2023

Feb 14, 2024

BUY
$8.6 - $14.94 $43,430 - $75,447
5,050 Added 14.13%
40,796 $607,000
Q3 2023

Nov 13, 2023

SELL
$9.81 - $12.62 $34,178 - $43,968
-3,484 Reduced 8.88%
35,746 $401,000
Q2 2023

Aug 11, 2023

BUY
$8.08 - $10.37 $23,310 - $29,917
2,885 Added 7.94%
39,230 $394,000
Q1 2023

May 12, 2023

SELL
$8.79 - $14.58 $71,620 - $118,797
-8,148 Reduced 18.31%
36,345 $341,000
Q4 2022

Feb 14, 2023

SELL
$11.49 - $13.65 $131,445 - $156,156
-11,440 Reduced 20.45%
44,493 $544,000
Q3 2022

Nov 10, 2022

SELL
$12.41 - $32.42 $90,468 - $236,341
-7,290 Reduced 11.53%
55,933 $694,000
Q2 2022

Aug 15, 2022

SELL
$19.63 - $26.62 $487,373 - $660,921
-24,828 Reduced 28.2%
63,223 $1.24 Million
Q1 2022

May 13, 2022

SELL
$24.65 - $29.0 $316,678 - $372,563
-12,847 Reduced 12.73%
88,051 $2.3 Million
Q4 2021

Feb 14, 2022

SELL
$27.74 - $34.09 $1.94 Million - $2.38 Million
-69,862 Reduced 40.91%
100,898 $2.86 Million
Q3 2021

Nov 15, 2021

SELL
$29.2 - $36.72 $23.5 Million - $29.6 Million
-806,168 Reduced 82.52%
170,760 $5.45 Million
Q2 2021

Aug 24, 2021

BUY
$28.76 - $35.98 $506,981 - $634,255
17,628 Added 1.84%
976,928 $33.9 Million
Q1 2021

May 07, 2021

BUY
$27.85 - $34.49 $210,267 - $260,399
7,550 Added 0.79%
959,300 $28.3 Million
Q4 2020

Feb 16, 2021

BUY
$27.53 - $33.79 $624,628 - $766,661
22,689 Added 2.44%
951,750 $29.2 Million
Q3 2020

Nov 13, 2020

BUY
$21.1 - $29.13 $516,506 - $713,073
24,479 Added 2.71%
929,061 $25.9 Million
Q2 2020

Aug 14, 2020

BUY
$18.94 - $24.93 $384,803 - $506,502
20,317 Added 2.3%
904,582 $19.4 Million
Q1 2020

May 14, 2020

BUY
$16.68 - $32.25 $13.3 Million - $25.7 Million
796,111 Added 903.09%
884,265 $19.8 Million
Q4 2019

Feb 13, 2020

BUY
$25.29 - $29.45 $205,531 - $239,340
8,127 Added 10.16%
88,154 $2.6 Million
Q3 2019

Nov 13, 2019

BUY
$25.62 - $34.96 $1.65 Million - $2.25 Million
64,288 Added 408.46%
80,027 $2.13 Million
Q2 2019

Aug 14, 2019

BUY
$31.11 - $34.79 $489,640 - $547,559
15,739 New
15,739 $532,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Mariner, LLC Portfolio

Follow Mariner, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.